Skip to main content
. 2021 Jul 26;25:261. doi: 10.1186/s13054-021-03660-z

Fig. 2.

Fig. 2

Kaplan–Meier curves for the probability of being ESBL-E-free. a Unweighted Kaplan–Meier survival curves obtained by the strategy used in the all-ICU patients. b Propensity score-weighted Kaplan–Meier survival curves obtained by the strategy used in the all-ICU patients. c Unweighted Kaplan–Meier survival curves obtained by the strategy used in the subgroup of patients receiving antibiotherapy. d Propensity score-weighted Kaplan–Meier survival curves obtained by the strategy used in the subgroup of patients receiving antibiotherapy. e Unweighted Kaplan–Meier survival curves obtained by the strategy used in the subgroup of patients in septic shock. f Propensity score-weighted Kaplan–Meier survival curves obtained by the strategy used in the subgroup of patients in septic shock. ESBL-E: Extended-spectrum beta-lactamase-producing Enterobacteriaceae, HR: hazard ratio